On the public citation graph

Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications

https://doi.org/10.4161/mabs.28693
0 signed · 169 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/jps.22758openalex-snapshot
Developability Index: A Rapid In Silico Tool for the Screening of Antibody Aggregation Propensity
inferredcites →https://doi.org/10.1016/0021-9673(86)80064-4openalex-snapshot
High-performance hydrophobic-interaction chromatography of proteins on a series of poly(alkyl aspart-amide)-silicas
inferredcites →https://doi.org/10.1016/0161-5890(92)90185-zopenalex-snapshot
Microheterogeneity of a purified IgG1, due to asymmetric fab glycosylation
inferredcites →https://doi.org/10.1016/0165-022x(93)90019-kopenalex-snapshot
Single-step purification of F(ab′)2μ fragments of mouse monoclonal antibodies (immunoglobulins M) by hydrophobic interaction high-performance liquid chromatography using TSKgel Ether-5PW
inferredcites →https://doi.org/10.1016/j.chroma.2008.10.078openalex-snapshot
Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions
inferredcites →https://doi.org/10.1016/j.chroma.2010.10.107openalex-snapshot
Separation of oxidized variants of a monoclonal antibody by anion-exchange
inferredcites →https://doi.org/10.1016/j.ijpharm.2011.09.017openalex-snapshot
Impact of short range hydrophobic interactions and long range electrostatic forces on the aggregation kinetics of a monoclonal antibody and a dual-variable domain immunoglobulin at low and high concentrations
inferredcites →https://doi.org/10.1016/j.jchromb.2008.01.041openalex-snapshot
Liquid chromatography of recombinant proteins and protein drugs
inferredcites →https://doi.org/10.1016/j.jchromb.2011.03.006openalex-snapshot
HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining region
inferredcites →https://doi.org/10.1016/j.jmb.2009.06.028openalex-snapshot
Aggregation-Prone Motifs in Human Immunoglobulin G
inferredcites →https://doi.org/10.1016/j.pep.2007.02.010openalex-snapshot
The effects of arginine on protein binding and elution in hydrophobic interaction and ion-exchange chromatography
inferredcites →https://doi.org/10.1016/s0168-1656(01)00237-1openalex-snapshot
Hydrophobic interaction chromatography of proteins
inferredcites →https://doi.org/10.1016/s0731-7085(97)00153-2openalex-snapshot
An adaptation of hydrophobic interaction chromatography for estimation of protein solubility optima
inferredcites →https://doi.org/10.1021/ac702245copenalex-snapshot
Separation and Characterization of an IgG2 Antibody Containing a Cyclic Imide in CDR1 of Light Chain by Hydrophobic Interaction Chromatography and Mass Spectrometry
inferredcites →https://doi.org/10.1021/bi061500topenalex-snapshot
Aspartate Isomerization in the Complementarity-Determining Regions of Two Closely Related Monoclonal Antibodies
inferredcites →https://doi.org/10.1023/b:pham.0000029275.41323.a6openalex-snapshot
Structure-Immunogenicity Relationships of Therapeutic Proteins
inferredcites →https://doi.org/10.1038/nbt1030openalex-snapshot
Characterizing biological products and assessing comparability following manufacturing changes
inferredcites →https://doi.org/10.1038/nchembio847openalex-snapshot
Natural expansion of the genetic code
inferredcites →https://doi.org/10.1038/nrd3746openalex-snapshot
Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars
inferredcites →https://doi.org/10.1073/pnas.0904191106openalex-snapshot
Design of therapeutic proteins with enhanced stability
inferredcites →https://doi.org/10.1074/jbc.m110.160457openalex-snapshot
Classification and Characterization of Therapeutic Antibody Aggregates
inferredcites →https://doi.org/10.1093/glycob/cwn116openalex-snapshot
O-Fucosylation of an antibody light chain: Characterization of a modification occurring on an IgG1 molecule
inferredcites →https://doi.org/10.1093/protein/gzq037openalex-snapshot
Structure-based engineering of a monoclonal antibody for improved solubility
inferredcites →https://doi.org/10.1093/protein/gzs042openalex-snapshot
Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions
inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-0789openalex-snapshot
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
inferredcites →https://doi.org/10.1186/1472-6807-4-4openalex-snapshot
Fast identification of folded human protein domains expressed in E. coli suitable for structural analysis
inferredcites →https://doi.org/10.1517/14712598.2012.758710openalex-snapshot
Biosimilar monoclonal antibodies: a science-based regulatory challenge
inferredcites →https://doi.org/10.4049/jimmunol.151.3.1548openalex-snapshot
Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
inferredcites →https://doi.org/10.4161/mabs.21328openalex-snapshot
Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies
inferredcites →https://doi.org/10.4161/mabs.24458openalex-snapshot
Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule
inferredcites →https://doi.org/10.4161/mabs.25269openalex-snapshot
Developability studies before initiation of process development
inferredcites →https://doi.org/10.4161/mabs.3.2.14960openalex-snapshot
Analytical methods for physicochemical characterization of antibody drug conjugates
inferredcites →https://doi.org/10.4161/mabs.3.4.15677openalex-snapshot
Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and Thioflavin T binding

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4622058openalex-extracted
inferred← citeshttps://doi.org/10.1002/0471266949.bmc160openalex-snapshot
Process Development of Protein Therapeutics
inferred← citeshttps://doi.org/10.1002/0471266949.bmc160.pub2openalex-snapshot
Process Development of Protein Therapeutics
inferred← citeshttps://doi.org/10.1002/9781119126942.ch7openalex-snapshot
HYDROPHOBIC INTERACTION CHROMATOGRAPHY FOR THE PURIFICATION OF ANTIBODIES
inferred← citeshttps://doi.org/10.1002/9781119313786.ch12openalex-snapshot
HPLC and UHPLC for Biopharmaceutical Analysis
inferred← citeshttps://doi.org/10.1002/9781119413073.ch4openalex-snapshot
Modern Liquid Chromatography and Mass Spectrometry for Targeted Biomarker Quantitation
inferred← citeshttps://doi.org/10.1002/9781119678496.ch10openalex-snapshot
Native Mass Spectrometry in Drug Discovery and Development
inferred← citeshttps://doi.org/10.1002/9781394236145.ch12openalex-snapshot
High‐Throughput Biophysical Assays for Developability Assessment
inferred← citeshttps://doi.org/10.1002/9783527699124.ch14openalex-snapshot
Stability, Formulation, and Delivery of Biopharmaceuticals
inferred← citeshttps://doi.org/10.1002/elps.201800067openalex-snapshot
Complementary middle‐down and intact monoclonal antibody proteoform characterization by capillary zone electrophoresis – mass spectrometry
inferred← citeshttps://doi.org/10.1002/elps.202400158openalex-snapshot
Offline Coupling of Hydrophobic Interaction Chromatography–Capillary Zone Electrophoresis for Monitoring Charge‐Based Heterogeneity of Recombinant Monoclonal Antibodies
inferred← citeshttps://doi.org/10.1002/jps.24430openalex-snapshot
Developability Assessment During the Selection of Novel Therapeutic Antibodies
inferred← citeshttps://doi.org/10.1007/978-1-0716-1450-1_4openalex-snapshot
Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods
inferred← citeshttps://doi.org/10.1007/978-1-4939-9929-3_10openalex-snapshot
ADC Analysis by Hydrophobic Interaction Chromatography
inferred← citeshttps://doi.org/10.1007/978-3-031-94551-9_8openalex-snapshot
RP-HPLC: A Versatile Technique for Identification, Isolation, and Characterization of Therapeutic Antibodies
inferred← citeshttps://doi.org/10.1007/978-981-16-5485-5_3openalex-snapshot
Separation Modes
inferred← citeshttps://doi.org/10.1007/s00216-022-04366-zopenalex-snapshot
Development, validation, and implementation of a robust and quality control-friendly focused peptide mapping method for monitoring oxidation of co-formulated monoclonal antibodies
inferred← citeshttps://doi.org/10.1007/s00216-023-04547-4openalex-snapshot
Revealing charge heterogeneity of stressed trastuzumab at the subunit level
inferred← citeshttps://doi.org/10.1007/s00253-016-7388-9openalex-snapshot
Advances in recombinant antibody manufacturing
inferred← citeshttps://doi.org/10.1007/s10822-021-00429-yopenalex-snapshot
Explicit solvation thermodynamics in ionic solution: extending grid inhomogeneous solvation theory to solvation free energy of salt–water mixtures
inferred← citeshttps://doi.org/10.1007/s13361-015-1203-1openalex-snapshot
Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates
inferred← citeshttps://doi.org/10.1007/s44211-025-00748-2openalex-snapshot
Current advances in separation chemistry for antibody purification and analysis
inferred← citeshttps://doi.org/10.1016/b978-0-12-415807-8.00006-7openalex-snapshot
Hydrophobic Interaction Chromatography
inferred← citeshttps://doi.org/10.1016/b978-0-12-805393-5.00007-5openalex-snapshot
Hydrophobic interaction chromatography *
inferred← citeshttps://doi.org/10.1016/b978-0-12-822318-5.00005-3openalex-snapshot
Advanced structural elucidation of new antibody formats by mass spectrometry
inferred← citeshttps://doi.org/10.1016/b978-0-323-99968-7.00026-6openalex-snapshot
Hydrophobic interaction chromatography
inferred← citeshttps://doi.org/10.1016/j.aca.2020.12.064openalex-snapshot
Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis
inferred← citeshttps://doi.org/10.1016/j.actbio.2026.06.053openalex-snapshot
Cross-scale biomimicry of resilin and resilin-like proteins: From phase separation and dityrosine photocrosslinking to tissue repair and soft robotic devices
inferred← citeshttps://doi.org/10.1016/j.biologicals.2017.04.005openalex-snapshot
Considerations of critical quality attributes in the analytical comparability assessment of biosimilar products
inferred← citeshttps://doi.org/10.1016/j.bpj.2020.11.010openalex-snapshot
Conformational Ensembles of Antibodies Determine Their Hydrophobicity
inferred← citeshttps://doi.org/10.1016/j.cell.2016.05.024openalex-snapshot
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity
inferred← citeshttps://doi.org/10.1016/j.celrep.2019.08.056openalex-snapshot
Affinity Maturation Enhances Antibody Specificity but Compromises Conformational Stability
inferred← citeshttps://doi.org/10.1016/j.chroma.2015.12.068openalex-snapshot
Analysis of monoclonal antibody oxidation by simple mixed mode chromatography
inferred← citeshttps://doi.org/10.1016/j.chroma.2016.06.085openalex-snapshot
High throughput peptide mapping method for analysis of site specific monoclonal antibody oxidation
inferred← citeshttps://doi.org/10.1016/j.chroma.2016.09.008openalex-snapshot
Separation of monoclonal antibody charge state variants by open tubular capillary electrochromatography with immobilised protein as stationary phase
inferred← citeshttps://doi.org/10.1016/j.chroma.2016.12.047openalex-snapshot
Optimization of non-linear gradient in hydrophobic interaction chromatography for the analytical characterization of antibody-drug conjugates
inferred← citeshttps://doi.org/10.1016/j.chroma.2018.11.080openalex-snapshot
On-line coupling of hydrophobic interaction column with reverse phase column -charged aerosol detector/mass spectrometer to characterize polysorbates in therapeutic protein formulations
inferred← citeshttps://doi.org/10.1016/j.chroma.2019.03.044openalex-snapshot
Streamlining the polishing step development process via physicochemical characterization of monoclonal antibody aggregates
inferred← citeshttps://doi.org/10.1016/j.chroma.2022.463696openalex-snapshot
Purification of hydrophobic complex antibody formats using a moderately hydrophobic mixed mode cation exchange resin
inferred← citeshttps://doi.org/10.1016/j.chroma.2023.464585openalex-snapshot
The beneficial impact of kosmotropic salts on the resolution and selectivity of Protein A chromatography
inferred← citeshttps://doi.org/10.1016/j.chroma.2025.466089openalex-snapshot
The current state-of-the-art approaches and emerging opportunities for hydrophobic interaction chromatography for the characterization of intact proteins and biotherapeutics
inferred← citeshttps://doi.org/10.1016/j.crbiot.2023.100139openalex-snapshot
The effect of kosmotropic salts on aggregate removal from monoclonal antibodies in mixed-mode anion exchange chromatography
inferred← citeshttps://doi.org/10.1016/j.csbj.2024.06.016openalex-snapshot
A comprehensive overview of recent advances in generative models for antibodies
inferred← citeshttps://doi.org/10.1016/j.ejpb.2026.115160openalex-snapshot
From candidate ranking to lead identification – Hydrophobic interaction chromatography, PAIA, and structure-based calculations for hydrophobicity determination during developability assessment of mAbs and a mAb-derived fusion protein
inferred← citeshttps://doi.org/10.1016/j.forc.2022.100434openalex-snapshot
Differentiation and verification of monoclonal antibody therapeutics by integrating accurate mass analyses at intact, subunit and subdomain levels for forensic investigation
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2021.120723openalex-snapshot
Investigating photodegradation of antibodies governed by the light dosage
inferred← citeshttps://doi.org/10.1016/j.jchromb.2016.04.037openalex-snapshot
Challenges in liquid chromatographic characterization of proteins
inferred← citeshttps://doi.org/10.1016/j.jchromb.2016.05.012openalex-snapshot
A comprehensive study to protein retention in hydrophobic interaction chromatography
inferred← citeshttps://doi.org/10.1016/j.jchromb.2016.06.048openalex-snapshot
Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I − Optimization of separation conditions
inferred← citeshttps://doi.org/10.1016/j.jchromb.2016.06.049openalex-snapshot
Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. II- Identification of sub-units for the characterization of even and odd load drug species
inferred← citeshttps://doi.org/10.1016/j.jchromb.2017.05.010openalex-snapshot
Protocols for the analytical characterization of therapeutic monoclonal antibodies. I – Non-denaturing chromatographic techniques
inferred← citeshttps://doi.org/10.1016/j.jchromb.2021.123026openalex-snapshot
Isolation, physicochemical, and structure–function relationship of the hydrophobic variant of Fc-fusion proteins that bind to TNF-α receptor, HS002 and HS002A
inferred← citeshttps://doi.org/10.1016/j.jchromb.2023.123981openalex-snapshot
Structure-function relationship study for sulfated protein therapeutics using hydrophobic interaction chromatography and mass spectrometry
inferred← citeshttps://doi.org/10.1016/j.jchromb.2026.124920openalex-snapshot
Impacts of methionine oxidation on product quality and anti-tumor activity of a therapeutic monoclonal antibody
inferred← citeshttps://doi.org/10.1016/j.jcoa.2021.100025openalex-snapshot
Analytical tools for the characterization of deamidation in monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.jconrel.2015.10.038openalex-snapshot
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers
inferred← citeshttps://doi.org/10.1016/j.jpba.2015.11.011openalex-snapshot
Practical method development for the separation of monoclonal antibodies and antibody-drug-conjugate species in hydrophobic interaction chromatography, part 1: optimization of the mobile phase
inferred← citeshttps://doi.org/10.1016/j.jpba.2016.01.037openalex-snapshot
Practical method development for the separation of monoclonal antibodies and antibody-drug-conjugate species in hydrophobic interaction chromatoraphy, part 2: Optimization of the phase system
inferred← citeshttps://doi.org/10.1016/j.jpba.2016.04.004openalex-snapshot
Hydrophobic interaction chromatography for the characterization of monoclonal antibodies and related products
inferred← citeshttps://doi.org/10.1016/j.jpba.2016.08.019openalex-snapshot
Impact of organic modifier and temperature on protein denaturation in hydrophobic interaction chromatography
inferred← citeshttps://doi.org/10.1016/j.jpba.2017.01.004openalex-snapshot
Mixed-mode reversed phase/positively charged repulsion chromatography for intact protein separation
inferred← citeshttps://doi.org/10.1016/j.jpba.2017.03.014openalex-snapshot
Facile preparation of fibrin coated open tubular column for characterization of monoclonal antibody variants by capillary electrochromatography
inferred← citeshttps://doi.org/10.1016/j.jpba.2018.08.024openalex-snapshot
Recent advancements, challenges, and practical considerations in the mass spectrometry-based analytics of protein biotherapeutics: A viewpoint from the biosimilar industry
inferred← citeshttps://doi.org/10.1016/j.jpba.2020.113131openalex-snapshot
Analytical artifacts in characterization of recombinant monoclonal antibody therapeutics
inferred← citeshttps://doi.org/10.1016/j.jpba.2020.113178openalex-snapshot
Bridging size and charge variants of a therapeutic monoclonal antibody by two-dimensional liquid chromatography
inferred← citeshttps://doi.org/10.1016/j.jpba.2020.113251openalex-snapshot
Recent advances in LC–MS based characterization of protein-based bio-therapeutics – mastering analytical challenges posed by the increasing format complexity
inferred← citeshttps://doi.org/10.1016/j.jpba.2020.113313openalex-snapshot
Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products
inferred← citeshttps://doi.org/10.1016/j.jpba.2020.113703openalex-snapshot
A hydrophobic interaction chromatography method suitable for quantitating individual monoclonal antibodies contained in co-formulated drug products
inferred← citeshttps://doi.org/10.1016/j.jpba.2023.115696openalex-snapshot
Recent advances in structural mass spectrometry methods in the context of biosimilarity assessment: from sequence heterogeneities to higher order structures
inferred← citeshttps://doi.org/10.1016/j.memsci.2019.117305openalex-snapshot
An annular-flow, hollow-fiber membrane chromatography device for fast, high-resolution protein separation at low pressure
inferred← citeshttps://doi.org/10.1016/j.xphs.2019.08.018openalex-snapshot
Structure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit
inferred← citeshttps://doi.org/10.1016/j.xphs.2021.09.006openalex-snapshot
Characterization of N-Terminal Glutamate Cyclization in Monoclonal Antibody and Bispecific Antibody Using Charge Heterogeneity Assays and Hydrophobic Interaction Chromatography
inferred← citeshttps://doi.org/10.1016/j.xphs.2021.11.024openalex-snapshot
Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy
inferred← citeshttps://doi.org/10.1016/j.xphs.2024.11.005openalex-snapshot
Limitation of anion exchange chromatography and potential application of hydrophobic interaction chromatography for monitoring AAV9 capsid degradation upon thermal stress
inferred← citeshttps://doi.org/10.1016/j.xphs.2025.103820openalex-snapshot
Comparative evaluation of chelators in the context of analysis of antibody oxidative stability
inferred← citeshttps://doi.org/10.1021/acs.analchem.2c02931openalex-snapshot
Multiattribute Monitoring of Charge-Based Heterogeneity of Recombinant Monoclonal Antibodies Using 2D HIC-WCX-MS
inferred← citeshttps://doi.org/10.1021/acs.analchem.3c04011openalex-snapshot
Selectivity and Resolving Power of Hydrophobic Interaction Chromatography Targeting the Separation of Monoclonal Antibody Variants
inferred← citeshttps://doi.org/10.1021/acs.analchem.5b00788openalex-snapshot
Tandem Native Mass-Spectrometry on Antibody–Drug Conjugates and Submillion Da Antibody–Antigen Protein Assemblies on an Orbitrap EMR Equipped with a High-Mass Quadrupole Mass Selector
inferred← citeshttps://doi.org/10.1021/acs.analchem.5b04285openalex-snapshot
Online Hydrophobic Interaction Chromatography–Mass Spectrometry for Top-Down Proteomics
inferred← citeshttps://doi.org/10.1021/acs.analchem.5b04561openalex-snapshot
Chromatographic, Electrophoretic, and Mass Spectrometric Methods for the Analytical Characterization of Protein Biopharmaceuticals
inferred← citeshttps://doi.org/10.1021/acs.analchem.5c03553openalex-snapshot
Real-Time Bioconjugation Reaction Monitoring of Antibody–Drug Conjugates with Multiattribute High-Throughput Hydrophobic Interaction Chromatography
inferred← citeshttps://doi.org/10.1021/acs.analchem.6c00901openalex-snapshot
Evaluating Antibody Quality via Simultaneous Size and Charge Measurement with Single Protein Oscillators
inferred← citeshttps://doi.org/10.1021/acs.analchem.7b01755openalex-snapshot
A Generic HPLC Method for Absolute Quantification of Oxidation in Monoclonal Antibodies and Fc-Fusion Proteins Using UV and MS Detection
inferred← citeshttps://doi.org/10.1021/acs.analchem.7b02110openalex-snapshot
An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug Conjugates
inferred← citeshttps://doi.org/10.1021/acs.analchem.8b01322openalex-snapshot
Asparagine Deamidation in a Complementarity Determining Region of a Recombinant Monoclonal Antibody in Complex with Antigen
inferred← citeshttps://doi.org/10.1021/acs.analchem.8b01865openalex-snapshot
Online Hydrophobic Interaction Chromatography–Mass Spectrometry for the Analysis of Intact Monoclonal Antibodies
inferred← citeshttps://doi.org/10.1021/acs.analchem.9b02192openalex-snapshot
Comparison of Analytical Methods for Antibody–Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP
inferred← citeshttps://doi.org/10.1021/acs.analchem.9b02454openalex-snapshot
Streamlined Characterization of an Antibody–Drug Conjugate by Two-Dimensional and Four-Dimensional Liquid Chromatography/Mass Spectrometry
inferred← citeshttps://doi.org/10.1021/acs.analchem.9b04467openalex-snapshot
Native Hydrophobic Interaction Chromatography Hyphenated to Mass Spectrometry for Characterization of Monoclonal Antibody Minor Variants
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6c00166openalex-snapshot
Selection of Functional Glycoforms in Anti-SARS-CoV-2 Human IgG1 Monoclonal Antibodies by FcγRIIIa Affinity Chromatography and Mass Spectrometry
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.1c00280openalex-snapshot
Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties
inferred← citeshttps://doi.org/10.1021/acs.oprd.6b00072openalex-snapshot
RP-HPLC DAR Characterization of Site-Specific Antibody Drug Conjugates Produced in a Cell-Free Expression System
inferred← citeshttps://doi.org/10.1021/acsptsci.4c00296openalex-snapshot
In-Depth Characterization for Methionine Oxidization in Complementary Domain Region by Hydrophobic Interaction Chromatography
inferred← citeshttps://doi.org/10.1021/jasms.1c00036openalex-snapshot
Denaturing and Native Mass Spectrometric Analytics for Biotherapeutic Drug Discovery Research: Historical, Current, and Future Personal Perspectives
inferred← citeshttps://doi.org/10.1021/jasms.3c00175openalex-snapshot
A Research Journey: Over a Decade of Denaturing and Native-MS Analyses of Hydrophobic and Membrane Proteins in Amgen Therapeutic Discovery
inferred← citeshttps://doi.org/10.1021/jasms.4c00348openalex-snapshot
Evolution of Mass Spectrometers for High m/z Biological Ion Formation, Transmission, Analysis and Detection: A Personal Perspective
inferred← citeshttps://doi.org/10.1021/jasms.5c00284openalex-snapshot
Assessing the Impact of CDR Deamidation and Isomerization on mAb Target Binding Using Affinity-Resolved 2D-SEC-SCX-MS Analysis
inferred← citeshttps://doi.org/10.1038/s41551-023-01074-6openalex-snapshot
Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning
inferred← citeshttps://doi.org/10.1038/s41570-021-00353-7openalex-snapshot
Studying protein structure and function by native separation–mass spectrometry
inferred← citeshttps://doi.org/10.1038/s41570-022-00438-xopenalex-snapshot
Non-specificity as the sticky problem in therapeutic antibody development
inferred← citeshttps://doi.org/10.1038/s41598-017-04320-5openalex-snapshot
The structure-function relationship of disulfide bonds in etanercept
inferred← citeshttps://doi.org/10.1039/c6an01520dopenalex-snapshot
Computer assisted liquid chromatographic method development for the separation of therapeutic proteins
inferred← citeshttps://doi.org/10.1080/14712598.2021.1846714openalex-snapshot
An overview of process development for antibody-drug conjugates produced by chemical conjugation technology
inferred← citeshttps://doi.org/10.1080/19420862.2015.1016694openalex-snapshot
An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies
inferred← citeshttps://doi.org/10.1080/19420862.2016.1160179openalex-snapshot
Cysteinylation of a monoclonal antibody leads to its inactivation
inferred← citeshttps://doi.org/10.1080/19420862.2016.1171444openalex-snapshot
Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering
inferred← citeshttps://doi.org/10.1080/19420862.2016.1193659openalex-snapshot
Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept
inferred← citeshttps://doi.org/10.1080/19420862.2016.1226715openalex-snapshot
Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion
inferred← citeshttps://doi.org/10.1080/19420862.2016.1231277openalex-snapshot
Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies
inferred← citeshttps://doi.org/10.1080/19420862.2017.1279773openalex-snapshot
Subunit mass analysis for monitoring antibody oxidation
inferred← citeshttps://doi.org/10.1080/19420862.2018.1475871openalex-snapshot
Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodies
inferred← citeshttps://doi.org/10.1080/19420862.2018.1553476openalex-snapshot
Structure, heterogeneity and developability assessment of therapeutic antibodies
inferred← citeshttps://doi.org/10.1080/19420862.2020.1738691openalex-snapshot
Analytical characterization of coformulated antibodies as combination therapy
inferred← citeshttps://doi.org/10.1080/19420862.2020.1815995openalex-snapshot
An accelerated surface-mediated stress assay of antibody instability for developability studies
inferred← citeshttps://doi.org/10.1080/19420862.2021.2023938openalex-snapshot
In silico prediction of post-translational modifications in therapeutic antibodies
inferred← citeshttps://doi.org/10.1080/19420862.2023.2171248openalex-snapshot
Assessing developability early in the discovery process for novel biologics
inferred← citeshttps://doi.org/10.1080/19420862.2023.2185924openalex-snapshot
Blueprint for antibody biologics developability
inferred← citeshttps://doi.org/10.1080/19420862.2023.2215887openalex-snapshot
Design of antibody variable fragments with reduced reactivity to preexisting anti-drug antibodies
inferred← citeshttps://doi.org/10.1080/19420862.2023.2256745openalex-snapshot
Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies
inferred← citeshttps://doi.org/10.1080/19420862.2024.2362788openalex-snapshot
Molecular surface descriptors to predict antibody developability: sensitivity to parameters, structure models, and conformational sampling
inferred← citeshttps://doi.org/10.1080/19420862.2025.2474521openalex-snapshot
PROPERMAB: an integrative framework for in silico prediction of antibody developability using machine learning
inferred← citeshttps://doi.org/10.1080/21645515.2022.2122507openalex-snapshot
Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development
inferred← citeshttps://doi.org/10.1093/protein/gzag003openalex-snapshot
VIF-Ig: a novel fc framework for ADCC by incorporation of VHH unit
inferred← citeshttps://doi.org/10.1101/2023.07.18.549448openalex-snapshot
Molecular Surface Descriptors to Predict Antibody Developability
inferred← citeshttps://doi.org/10.1248/cpb.c21-00258openalex-snapshot
Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates
inferred← citeshttps://doi.org/10.1371/journal.pone.0210712openalex-snapshot
Therapeutic Fc fusion protein misfolding: A three-phasic cultivation experimental design
inferred← citeshttps://doi.org/10.1371/journal.pone.0336791openalex-snapshot
Multispecific antibodies: Bioanalytics for early-stage screening and characterization of mispairing profiles
inferred← citeshttps://doi.org/10.1586/14789450.2016.1132167openalex-snapshot
Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates
inferred← citeshttps://doi.org/10.17760/d20259955openalex-snapshot
Top-down proteomic analysis of protein pharmaceuticals, mixtures of protein complexes, and ribosomal protein extracts by capillary zone electrophoresis-mass spectrometry
inferred← citeshttps://doi.org/10.33612/diss.603403111openalex-snapshot
Bioanalytical methodology to study the in vivo biotransformation of therapeutic proteins
inferred← citeshttps://doi.org/10.3389/fmolb.2022.960194openalex-snapshot
Comparison of hydrophobicity scales for predicting biophysical properties of antibodies
inferred← citeshttps://doi.org/10.3390/biom14080999openalex-snapshot
Charge Variants Characterization of Co-Formulated Antibodies by Three-Dimensional Liquid Chromatography–Mass Spectrometry
inferred← citeshttps://doi.org/10.3390/ijms21218037openalex-snapshot
QSAR Implementation for HIC Retention Time Prediction of mAbs Using Fab Structure: A Comparison between Structural Representations
inferred← citeshttps://doi.org/10.5282/edoc.17528openalex-snapshot
Influence of the antibody variable domain on FcRn-dependent pharmacokinetics
inferred← citeshttps://doi.org/10.5772/intechopen.89644openalex-snapshot
Preparing Proteoforms of Therapeutic Proteins for Top-Down Mass Spectrometry
inferred← citeshttps://doi.org/10.70675/94501199z1059z4dbez9356za0cd21ee3d9copenalex-snapshot
Hyphenation of non-denaturing liquid chromatography to native mass spectrometry for therapeutic protein characterization
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.